Glenview Capital Management, LLC Bausch Health Companies Inc. Transaction History

Glenview Capital Management, LLC

$5.16 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$6.1 - $10.41 $7.97 Million - $13.6 Million	1,307,068 New	1,307,068 $9.11 Million
Q2 2023 Aug 14, 2023	BUY	$5.72 - $8.8 $10.1 Million - $15.5 Million	1,766,395 New	1,766,395 $14.1 Million
Q4 2022 Feb 14, 2023	BUY	$6.09 - $7.93 $9.14 Million - $11.9 Million	1,500,000 New	1,500,000 $9.42 Million
Q2 2022 Aug 11, 2022	SELL	$7.06 - $23.63 $65.4 Million - $219 Million	-9,256,661 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$21.6 - $27.79 $70.1 Million - $90.2 Million	-3,245,486 Reduced 25.96%	9,256,661 $212 Million
Q4 2021 Feb 14, 2022	SELL	$23.0 - $29.01 $72.4 Million - $91.3 Million	-3,147,096 Reduced 20.11%	12,502,147 $345 Million
Q3 2021 Nov 15, 2021	SELL	$25.04 - $30.06 $17.2 Million - $20.7 Million	-688,306 Reduced 4.21%	15,649,243 $436 Million
Q2 2021 Aug 16, 2021	BUY	$27.43 - $32.7 $19.9 Million - $23.7 Million	724,459 Added 4.64%	16,337,549 $479 Million
Q1 2021 May 17, 2021	SELL	$21.37 - $34.38 $17.5 Million - $28.2 Million	-820,929 Reduced 5.0%	15,613,090 $496 Million
Q4 2020 Feb 16, 2021	BUY	$15.31 - $21.12 $22.6 Million - $31.2 Million	1,476,311 Added 9.87%	16,434,019 $342 Million
Q3 2020 Nov 16, 2020	SELL	$14.88 - $20.13 $10.2 Million - $13.8 Million	-686,420 Reduced 4.39%	14,957,708 $232 Million
Q2 2020 Aug 14, 2020	SELL	$13.31 - $20.51 $12.9 Million - $20 Million	-972,880 Reduced 5.85%	15,644,128 $286 Million
Q4 2019 Feb 14, 2020	BUY	$18.89 - $31.89 $53 Million - $89.5 Million	2,806,494 Added 20.32%	16,617,008 $497 Million
Q3 2019 Nov 14, 2019	BUY	$20.88 - $25.66 $85.5 Million - $105 Million	4,095,270 Added 42.15%	13,810,514 $302 Million
Q2 2019 Aug 14, 2019	BUY	$20.52 - $26.45 $8.21 Million - $10.6 Million	400,000 Added 4.29%	9,715,244 $245 Million
Q1 2019 May 15, 2019	BUY	$20.23 - $26.29 $55.1 Million - $71.6 Million	2,724,936 Added 41.35%	9,315,244 $230 Million
Q4 2018 Feb 14, 2019	BUY	$17.64 - $28.32 $54 Million - $86.7 Million	3,060,703 Added 86.72%	6,590,308 $122 Million
Q3 2018 Nov 14, 2018	BUY	$20.64 - $25.67 $72.9 Million - $90.6 Million	3,529,605 New	3,529,605 $90.6 Million

Others Institutions Holding BHC

# of Institutions

255

Shares Held

253M

Call Options Held

5.53M

Put Options Held

16.5M

Icahn Carl C Sunny Isles Beach, FL

34.7M
Shares

$294 Million
2.88% of portfolio
Goldentree Asset Management LP New York, NY

29.4M
Shares

$249 Million
21.8% of portfolio
John Paulson Paulson & Co. Inc. | New York, Ny

26.4M
Shares

$224 Million
14.7% of portfolio
National Bank Of Canada

15.6M
Shares

$133 Million
0.18% of portfolio
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A6

13M
Shares

$110 Million
0.26% of portfolio

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.07B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenview Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glenview Capital Management, LLC with notifications on news.

Account